Login
$MEDP
$673.79 -$2.98 (0.44%) Close

Ownership

13F as of Q2 2026 · 28.0M shares outstanding

Who owns MEDP?

By type of holder
Institutions 87.8% Insiders 12.2% Everyone else 0.0%
Concentration Top 10 holders own 72.2%
August J. Troendle 19.3% · Medpace Investors, LLC 16.9%
Institutional ownership
87.8%
+1.9 pts vs last qtr
Institutional holders
696
-35 vs last qtr
Net shares bought
+538.0K
by institutions in Q2 2026
New / sold out
74 / 109
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Price T Rowe Associates Inc /MD/ +1.8M
  • Norges Bank NEW +227.0K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • D. E. Shaw & Co., Inc. −198.1K
  • Mawer Investment Management Ltd. −178.9K

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$468M
20 notices from 9 people
Shares covered
785.0K
2.81% of the company
Arranged in advance
4%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$111.9M$223.7MNov 2025: $12.8M under a 10b5-1 planNov 2025: $210.9M without a planNovDecJanFebMar 2026: $14.5M without a planMarAprMay 2026: $7.4M without a planMayJunJul 2026: $7.0M under a 10b5-1 planJul 2026: $191.7M without a planJulAug 2026: $13.1M without a planAugSepOct 2026: $10.9M without a planOct
Largest proposed sellers
  • August J. Troendle Chairman $367M
  • Burwig Susan E Officer $38.4M

Sign up to see all 5.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
−18.7%
−2.28% a year
Each share's claim on the business
+23.0%
grew without buying or selling a share
Spent on buybacks vs paid in stock
$2.4B vs $172M
over 10 fiscal years
Diluted shares, split-adjusted
28.6M34.4M40.2M2016: 36.3M shares'162017: 39.8M shares'172018: 36.9M shares'182019: 37.6M shares'192020: 37.7M shares'202021: 37.7M shares'212022: 33.7M shares'222023: 31.8M shares'232024: 32.0M shares'242025: 29.5M shares'25
Buybacks Stock-based comp
$0$458.7M$917.4M2016 buybacks: $02016 stock comp: $9.8M'162017 buybacks: $155.6M2017 stock comp: $4.5M'172018 buybacks: $02018 stock comp: $6.5M'182019 buybacks: $02019 stock comp: $20.7M'192020 buybacks: $98.3M2020 stock comp: $13.8M'202021 buybacks: $62.1M2021 stock comp: $14.5M'212022 buybacks: $847.8M2022 stock comp: $21.4M'222023 buybacks: $144.0M2023 stock comp: $20.5M'232024 buybacks: $169.9M2024 stock comp: $25.5M'242025 buybacks: $917.4M2025 stock comp: $34.8M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years75% 3–5 years6% 1–3 years15% Under 1 year3%
Quarterly turnover
14.3%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting MEDP on Form 13F
B
BlackRock, Inc.
Shares
2.5M
% of company
8.93%
Change vs last qtr
+27.8K (+1.1%)
Held since
≤2021
PT
Price T Rowe Associates Inc /MD/
Shares
2.1M
% of company
7.40%
Change vs last qtr
+1.8M (+614.9%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding Medpace Holdings, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting MEDP on Form N-PORT; together they hold 36.5% of the company
IC
Position value
$409M
% of company
2.76%
% of the fund
0.33%
As of
June 30, 2026
VT
Position value
$384M
% of company
2.59%
% of the fund
0.02%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Medpace Holdings, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
AJ
August J. Troendle
5%+ holder13D · 19.1%
Shares
5.4M
% of company
19.29%
Change vs last qtr
—
Held since
—
MI
Medpace Investors, LLC
5%+ holder13D · 16.8%
Shares
4.7M
% of company
16.92%
Change vs last qtr
—
Held since
—

9 more holders behind a free account

See every insider and 5%+ holder of Medpace Holdings, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support